C17:0, rather than C15:0, drives the protective association of odd-chain saturated fatty acids with metabolic syndrome: mediation and joint effect evidence
摘要
Odd-chain saturated fatty acids (SFAs) have shown potential metabolic benefits, may exert protective metabolic effects. However, their association with MetS and the potential role of insulin resistance remains unclear.
MethodsIn a cross-sectional study of 746 adults, we assessed associations between erythrocyte odd-chain SFAs and MetS using logistic regression Mediation and interaction analyses were performed to explore the role of insulin resistance (HOMA-IR) in these associations. We also examined the correlations between odd-chain SFAs and dietary factors.
ResultsHigher erythrocyte C17:0 levels were associated with lower MetS risk (OR = 0.36, 95% CI 0.21–0.60), partially mediated by HOMA-IR (33.8%). Joint analysis revealed the lowest MetS risk among participants with both high C17:0 and low HOMA-IR (OR = 0.14, 95% CI 0.07–0.26). Additive interaction between C17:0 and HOMA-IR was significant. Dietary fiber intake was positively associated with C17:0 levels. No significant association was observed for C15:0.
ConclusionsElevated erythrocyte C17:0 is inversely associated with the risk of metabolic syndrome, partially through improved insulin sensitivity. Targeting the elevation of C17:0 levels and enhancing insulin sensitivity may offer a promising strategy for early MetS prevention. Dietary fiber may play a potential role in modulating C17:0 levels.